Feasibility of Personalised Health Behaviour Coaching to Support Symptoms and Activities of Daily Living in Those With Long COVID-19.
1 other identifier
interventional
32
1 country
1
Brief Summary
This pilot RCT aims to assess whether a simple PA behavioural modification intervention can be delivered safely and feasibly to individuals with Long COVID suffering long standing symptoms with concerns regarding their ability to perform activities of daily living. Participants will be randomised to receive an 8-week physical activity behavioural modification intervention alongside usual care or usual care alone. The primary outcome for this study is to assess the safety and feasibility of the intervention, including recruitment targets, randomisation, completion rates and acceptability to the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 28, 2023
CompletedFirst Posted
Study publicly available on registry
March 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2023
CompletedAugust 4, 2023
August 1, 2023
7 months
February 28, 2023
August 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Participant recruitment
At least 40% of eligible participants recruited to the study
8 weeks
Participant randomisation
At least 80% of participants randomised following informed consent
8 weeks
Participant completion
At least 80% of randomised participants completing the intervention period and post assessment visit
8 weeks
Participant acceptability
Assessed through a project tailored questionnaire on completing of the study
8 weeks
Secondary Outcomes (9)
Objective physical activity
8-weeks
Exercise capacity
8-weeks
Muscular strength and endurance
8-weeks
Lung Function
8-weeks
Health related quality of life
8-weeks
- +4 more secondary outcomes
Study Arms (2)
Physical activity behavioural modification
EXPERIMENTALThe 8-week PA behavioural modification intervention will focus on engaging participants in ADL and lowering sedentary time. Each participant will receive one semi-structured motivational interview at baseline to discuss favourite activities and barriers and facilitators to PA. Participants will produce an individualised action plan following the interview that will be followed throughout the intervention to allow an individualised approach to take place. Participants will then be provided with a low-cost pedometer and PA diary to self-monitor and record daily PA. The PA diary will provide examples of various activities that can be done in and around the house, with an emphasis placed on simple, effective movements to reduce sedentary time. Following this, a researcher will conduct weekly virtual meetings with the participant to discuss the past weeks PA levels and provide future individualised goals to promote ADL.
Usual Care
NO INTERVENTIONAll participants will be notified of the government 'your Covid recovery' programme (usual care) which provides details and support on managing long term symptoms of Covid-19.
Interventions
8-week intervention consisting motivational interview, individualised action plan and weekly consultations regarding activities of daily living and symptom management.
Eligibility Criteria
You may qualify if:
- People who are aged 18 years or older
- Have experienced at least one long COVID symptom for 12 weeks or longer
- Additionally meet at least one of the following criteria: 1) positive SARS-CoV-2 PCR or antigen test (positive COVID-19 test) during the acute phase of illness; 2) positive SARS-CoV-2 antibody test at any time point; 3) symptoms consistent with SARS-CoV-2 (COVID-19) infection during the acute phase.
You may not qualify if:
- Individuals who have previously been admitted to an intensive care unit (ICU) due to SARS-CoV-2
- Receiving palliative or end-of-life care
- Are actively participating in another research trial focused on long COVID
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bournemouth University
Bournemouth, Dorset, BH12 5BB, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Armstrong
Bournemouth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2023
First Posted
March 2, 2023
Study Start
November 1, 2022
Primary Completion
May 31, 2023
Study Completion
June 15, 2023
Last Updated
August 4, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share